The FDA approved a new blood test developed by Roche in partnership with Eli Lilly to help identify amyloid pathology linked to Alzheimer's Disease. One America's Stephanie Myers speaks with the senior medical manager in neurology for Roche, Joshua Kulas, about the development. Join this channel to get access to OAN Live & perks: https://www.youtube.com/channel/UCNbIDJNNgaRrXOD7VllIMRQ/join Visit us On OAN Live : https://live.oann.com/home.ktv Website: https://www.oann.com Facebook: https://www.facebook.com/OneAmericaNewsNetwork Twitter: https://twitter.com/OANN Instagram: https://www.instagram.com/one_america_news_ KlowdTV: Watch OAN Live on KlowdTV subscription prices start at $2.99 /mo https://klowdtv.com